Aardvark Therapeutics, Inc. Common Stock AARD Q2 2025 earnings
Reported August 13, 2025 · Before market open
EPS estimate-$0.60
Next report
Aug 12, 2026 (in a month)EPS estimate-$0.86
Financials
Q2 2025Valuation & ratios
Versus estimates
Diluted EPS
Ask the moment Aardvark Therapeutics, Inc. Common Stock reports.
Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.
Connect your AI
Claude
Questions, answered.
- When did Aardvark Therapeutics, Inc. Common Stock report Q2 2025 earnings?
- Aardvark Therapeutics, Inc. Common Stock (AARD) reported Q2 2025 earnings on August 13, 2025 before market open.
- What were Aardvark Therapeutics, Inc. Common Stock's Q2 2025 revenue and EPS?
- Aardvark Therapeutics, Inc. Common Stock reported revenue of - and diluted EPS of $-0.66 for Q2 2025.
- Did Aardvark Therapeutics, Inc. Common Stock beat estimates in Q2 2025?
- EPS missed the consensus estimate of $-0.60 by $0.06.
- How did Aardvark Therapeutics, Inc. Common Stock's Q2 2025 results compare year-over-year?
- Compared to the same quarter a year prior, diluted EPS grew 69.0% from $-2.13.
- Where can I find Aardvark Therapeutics, Inc. Common Stock's Q2 2025 SEC filings?
- You can read the 10-Q periodic report (0000950170-25-108116) directly on SEC EDGAR. The filing index links above go to sec.gov.